Teladoc Health
TDOC
205 hedge funds and large institutions have $2.64B invested in Teladoc Health in 2017 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 80 increasing their positions, 55 reducing their positions, and 22 closing their positions.
123% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 22
45% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 55
22% more capital invested
Capital invested by funds: $2.17B → $2.64B (+$469M)
17.15% more ownership
Funds ownership: 115.34% → 132.48% (+17%)
15% more funds holding
Funds holding: 178 → 205 (+27)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less call options, than puts
Call options by funds: $20.2M | Put options by funds: $38.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$43.2M |
| 2 |
Janus Henderson Group
London,
|
+$34.2M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$28.1M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$27.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$20.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tiger Global Management
New York
|
-$51.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$11.6M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$5.52M |
| 4 |
TC
Tavio Capital
New York
|
-$5.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.98M |
TDOC Hedge Fund Activity: Q4 2017 in Review
205 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q4 2017, worth a combined $2.64B — up 22% from $2.17B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new TDOC positions and 22 closed out — a net gain of 27 holders — while 80 added to existing stakes and 55 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $43.2M. The largest seller was Tiger Global Management, cutting an estimated $51.7M.
- 205 institutional investors held Teladoc Health (TDOC) as of Q4 2017, up from 178 in Q3 2017.
- Funds reported $2.64B of Teladoc Health stock for Q4 2017, up 22% quarter-over-quarter.
- 49 funds opened new Teladoc Health positions in Q4 2017 and 22 closed out, a net change of +27 holders.
- The largest Teladoc Health buyer in Q4 2017 was JP Morgan Chase, an estimated $43.2M added.
- The largest Teladoc Health seller in Q4 2017 was Tiger Global Management, an estimated $51.7M sold.
Based on aggregated 13F filings for Q4 2017.